DIAX (Nuveen Dow 30 Dynamic Overwrite Fund) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for DIAX and 80,000+ other tickers.
See exactly how DIAX's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for DIAX and 80,000+ other tickers.
The Nuveen Dow 30 Dynamic Overwrite Fund is a closed-end equity mutual fund, established by Nuveen Investments, Inc. and jointly overseen by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. This fund, domiciled in the U.S. and created on April 29, 2005 (formerly known as Dow 30 Premium & Dividend Income Fund Inc.), primarily allocates capital to large-cap companies across diversified sectors within the American public equity markets. Its strategy incorporates the use of call options, with the overarching goal of mirroring the performance of the Dow Jones Industrial Average.

CHICAGO--(BUSINESS WIRE)--The mergers of Nuveen S&P 500 Buy-Write Income Fund (NYSE: BXMX) and Nuveen Dow 30℠ Dynamic Overwrite Fund (NYSE: DIAX) into Nuveen S&P 500 Dynamic Overwrite Fund (NYSE: SPXX) were successfully completed prior to the opening of the New York Stock Exchange on March 30, 2026. Through the mergers, a wholly-owned subsidiary of SPXX acquired substantially all of the assets and liabilities of BXMX and DIAX in tax-free transactions, and common shares of each of BXMX a.

Nuveen Dow 30 Dynamic Overwrite Fund will merge into SPXX, shifting exposure from Dow Jones to the S&P 500 covered call strategy. Shareholders approved the merger, effective March 30, 2026, with DIAX holders receiving SPXX shares on a NAV-to-NAV basis. SPXX has historically underperformed peers in the S&P 500 covered call space; investors seeking Dow Jones exposure should consider alternatives post-merger.

CHICAGO--(BUSINESS WIRE)--Shareholders of Nuveen S&P 500 Buy-Write Income Fund (NYSE: BXMX), Nuveen Dow 30℠ Dynamic Overwrite Fund (NYSE: DIAX), and Nuveen S&P 500 Dynamic Overwrite Fund (NYSE: SPXX) have approved a proposal to merge the funds. The mergers will combine each of BXMX and DIAX into SPXX. Subject to the satisfaction of certain customary closing conditions, the mergers are expected to become effective before the market opens on March 30, 2026. Each fund has declared a regula.

Nuveen Dow 30 Dynamic Overwrite Fund remains a buy, offering a compelling 8% yield and trading at a 12.23% discount to NAV. DIAX's dynamic covered call strategy provides reliable income but limits upside during bull markets and does not protect against sharp downturns. Net investment income alone cannot support distributions; DIAX relies on net realized gains, making payout sustainability sensitive to market conditions.

Nuveen Dow 30 Dynamic Overwrite Fund is set to merge with SPXX and BXMX, aiming for a larger, more efficient fund. DIAX has suffered from structural issues and persistent underperformance, trading at a significant discount to NAV compared to peers. The proposed merger is expected to benefit DIAX shareholders by potentially narrowing the current -9.6% discount to NAV and improving performance.